FDA Inspection 1008395 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on April 10, 2017 in Scranton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 10, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Scranton, PA (United States)